Active

BioPharma Management and Consulting

Switched

BE0664691906

Rechtspersoon Private limited company 1 establishment

Viscourt(Cle) 2, 5650 Walcourt Overige zakelijke dienstverlening, neg

Active for

9 year, 10 months

Financials

Financial year 2025

Gross margin

€ 191,251

▼ 17% vs 2024

Profit

Healthy

€ 29,020

▼ 50% vs 2024

Debts

High

€ 3.1 million

▼ 3% vs 2024

BioPharma Management and Consulting from Walcourt, company number BE0664691906, closed financial year 2025 with a result of € 29,020 after tax. For that financial year BioPharma Management and Consulting recorded a gross margin of € 191,251 and equity of € 18,600. Compared with financial year 2024, the result moved from € 58,009 to € 29,020. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What happened at BioPharma Management and Consulting?

What happened at BioPharma Management and Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 29,020 (▼ 50% vs 2024). Source: NBB ↗
  • New establishment in Walcourt. KBO
  • Start of the company according to the CBE. KBO

In short

From € 289,788 profit in 2021 to € 29,020 profit in 2025.

Paid € 262,237 in corporate taxes since 2021.

Best year ever: 2021, with € 289,788 profit.

Paid out € 845,300 in dividends to the owners in total.

A new publication or filing at BioPharma Management and Consulting? We notify you, reason included.

Follow BioPharma Management and Consulting

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Denis Bedoret
BioPharma Management and Consulting

Behind BioPharma Management and Consulting is Denis Bedoret. Denis Bedoret is also behind NEUVASQ BIOTECHNOLOGIES and IMCYSE.

See the full network in the app

Directors

According to the 2025 annual accounts

Denis Bedoret

Administrator-manager

Also active at: NEUVASQ BIOTECHNOLOGIES, IMCYSE

Establishments

Establishment units

Physical locations of this company

Registered office

Viscourt(Cle) 2

5650 Walcourt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0664.691.906
VAT number
BE 0664.691.906
Registered office
Viscourt(Cle) 2, 5650 Walcourt
Names & denominations
BioPharma Management and Consulting · BM&C
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
17 October 2016
Peppol
Active · Active since 10 Aug 2026
Activities · NACE

Overige zakelijke dienstverlening, neg

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Overige vormen van onderwijs

Frequently asked questions

What is the enterprise number of BioPharma Management and Consulting?
The enterprise number of BioPharma Management and Consulting is BE0664691906.
What is the address of BioPharma Management and Consulting?
The registered office of BioPharma Management and Consulting is located at Viscourt(Cle) 2, 5650 Walcourt.
When was BioPharma Management and Consulting founded?
BioPharma Management and Consulting was founded on 17 October 2016.
What is the main activity of BioPharma Management and Consulting?
The main activity of BioPharma Management and Consulting is "Overige zakelijke dienstverlening, neg" (NACE code 82990).
Does BioPharma Management and Consulting have a website?
No website is currently known for BioPharma Management and Consulting.
How much profit did BioPharma Management and Consulting make in 2025?
BioPharma Management and Consulting posted a profit after taxes of € 29,020 in financial year 2025.
What is the revenue of BioPharma Management and Consulting?
As a small company, BioPharma Management and Consulting is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 191,251.
Where can I find the annual accounts of BioPharma Management and Consulting?
BioPharma Management and Consulting files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of BioPharma Management and Consulting?
According to the 2025 annual accounts, the directors of BioPharma Management and Consulting are: Denis Bedoret.
Who owns BioPharma Management and Consulting?
Behind BioPharma Management and Consulting is Denis Bedoret. Denis Bedoret is also behind NEUVASQ BIOTECHNOLOGIES and IMCYSE.